Related Experiment Video
Updated: Jun 20, 2026

08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Intramuscular granular cell tumor in the lower extremities
Eisuke Arai1, Yoshihiro Nishida, Satoshi Tsukushi
1Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan.
Clinical Orthopaedics and Related Research
|September 18, 2009
Summary
Granular cell tumors (GCTs) are rare neoplasms. While typically benign, malignant GCTs can occur, necessitating accurate diagnosis through imaging and histology for effective treatment.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Granular cell tumors (GCTs) are uncommon neoplasms with a predominantly benign histology.
- Malignant GCTs can occur, making differentiation from benign counterparts critical for patient management.
- Intramuscular GCTs, particularly in the lower extremities, require careful diagnostic and therapeutic consideration.
Purpose of the Study:
- To evaluate the diagnostic features and clinical outcomes of intramuscular granular cell tumors in the lower extremities.
- To highlight the importance of radiographic and histologic analysis in distinguishing benign from malignant GCTs.
Main Methods:
- Retrospective study of five cases of intramuscular granular cell tumors in the lower extremities.
- Histologic diagnosis of benign GCTs with wide surgical resection.
- Minimum 1-year follow-up to assess recurrence and metastasis.
- Analysis of characteristic MRI features (peripheral high intensity on T2-weighted images).
Main Results:
- Four out of five patients experienced no local recurrence or distant metastasis after a minimum 18-month follow-up.
- One patient with lymph node metastasis developed recurrence and distant metastasis, leading to death.
- Characteristic MRI findings can aid in the diagnosis of intramuscular GCTs.
- Histologic criteria (Fanburg-Smith et al.) are effective in differentiating malignant from benign GCTs.
Conclusions:
- Intramuscular granular cell tumors in the lower extremities can be diagnosed using MRI and histologic evaluation.
- Wide surgical resection is a suitable treatment for most extremity GCTs.
- Accurate differentiation between benign and malignant GCTs is essential for prognosis and treatment planning.
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...